Millennium Management’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.47M | Sell |
1,870,362
-1,072,513
| -36% | -$3.71M | ﹤0.01% | 1907 |
|
|
2025
Q1 | $7.71M | Buy |
2,942,875
+374,491
| +15% | +$981K | ﹤0.01% | 1693 |
|
|
2024
Q4 | $10.6M | Buy |
2,568,384
+1,508,777
| +142% | +$6.22M | 0.01% | 1522 |
|
|
2024
Q3 | $7.5M | Sell |
1,059,607
-89,570
| -8% | -$634K | ﹤0.01% | 1724 |
|
|
2024
Q2 | $7.49M | Buy |
1,149,177
+921,271
| +404% | +$6.01M | ﹤0.01% | 1656 |
|
|
2024
Q1 | $1.89M | Buy |
227,906
+40,940
| +22% | +$340K | ﹤0.01% | 2624 |
|
|
2023
Q4 | $2.06M | Sell |
186,966
-771,232
| -80% | -$8.49M | ﹤0.01% | 2439 |
|
|
2023
Q3 | $8.06M | Sell |
958,198
-615,959
| -39% | -$5.18M | ﹤0.01% | 1574 |
|
|
2023
Q2 | $19.8M | Buy |
+1,574,157
| New | +$19.8M | 0.01% | 996 |
|
|
2023
Q1 | – | Sell |
-575,136
| Closed | -$8.59M | – | 4895 |
|
|
2022
Q4 | $8.59M | Buy |
575,136
+534,902
| +1,329% | +$7.99M | ﹤0.01% | 1707 |
|
|
2022
Q3 | $900K | Sell |
40,234
-145,323
| -78% | -$3.25M | ﹤0.01% | 3404 |
|
|
2022
Q2 | $3.11M | Buy |
185,557
+171,797
| +1,249% | +$2.88M | ﹤0.01% | 2530 |
|
|
2022
Q1 | $412K | Sell |
13,760
-7,273
| -35% | -$218K | ﹤0.01% | 4202 |
|
|
2021
Q4 | $646K | Buy |
21,033
+3,275
| +18% | +$101K | ﹤0.01% | 3817 |
|
|
2021
Q3 | $560K | Buy |
+17,758
| New | +$560K | ﹤0.01% | 4090 |
|
|
2021
Q2 | – | Sell |
-22,958
| Closed | -$794K | – | 5300 |
|
|
2021
Q1 | $794K | Sell |
22,958
-46,737
| -67% | -$1.62M | ﹤0.01% | 3377 |
|
|
2020
Q4 | $2.9M | Buy |
+69,695
| New | +$2.9M | ﹤0.01% | 2262 |
|